LifeStance Health Group (NASDAQ:LFST - Get Free Report) issued its earnings results on Thursday. The company reported ($0.02) EPS for the quarter, topping analysts' consensus estimates of ($0.07) by $0.05, Briefing.com reports. LifeStance Health Group had a negative net margin of 13.05% and a negative return on equity of 10.51%. The company had revenue of $312.70 million for the quarter, compared to the consensus estimate of $302.25 million. During the same period in the previous year, the firm earned ($0.17) earnings per share. LifeStance Health Group's quarterly revenue was up 18.9% compared to the same quarter last year. LifeStance Health Group updated its FY 2024 guidance to EPS and its Q4 2024 guidance to EPS.
LifeStance Health Group Trading Down 4.2 %
NASDAQ LFST traded down $0.32 during trading on Friday, hitting $7.36. The stock had a trading volume of 3,799,092 shares, compared to its average volume of 1,082,470. The company has a quick ratio of 1.22, a current ratio of 1.22 and a debt-to-equity ratio of 0.20. The company has a market capitalization of $2.82 billion, a PE ratio of -17.95 and a beta of 1.24. The firm has a 50 day moving average price of $6.92 and a 200 day moving average price of $6.21. LifeStance Health Group has a twelve month low of $4.64 and a twelve month high of $9.20.
Insider Transactions at LifeStance Health Group
In related news, insider Ann Varanakis sold 5,269 shares of LifeStance Health Group stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $6.28, for a total value of $33,089.32. Following the completion of the transaction, the insider now owns 263,007 shares in the company, valued at approximately $1,651,683.96. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 6.60% of the company's stock.
Wall Street Analyst Weigh In
A number of equities research analysts have commented on LFST shares. UBS Group reduced their target price on LifeStance Health Group from $9.00 to $7.50 and set a "neutral" rating on the stock in a research report on Thursday, August 15th. Barclays lowered their target price on shares of LifeStance Health Group from $8.00 to $6.00 and set an "underweight" rating for the company in a research note on Friday, August 9th. One research analyst has rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus price target of $8.25.
Check Out Our Latest Research Report on LifeStance Health Group
LifeStance Health Group Company Profile
(
Get Free Report)
LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.
See Also
Before you consider LifeStance Health Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and LifeStance Health Group wasn't on the list.
While LifeStance Health Group currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
